Sagimet Biosciences Inc Series A Common Stock
Price & Volume
Stats
See moreOpen | $5.51 |
Previous Close | $5.42 |
Day Range | $5.50-$5.76 |
52W Range | $2.02-$11.41 |
Market Cap | $176.6M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.62 |
News
See moreYahoo Finance • 2 months ago
Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls
Yahoo Finance • 4 months ago
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
Yahoo Finance • 4 months ago
Sagimet Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 5 months ago
Sagimet Biosciences GAAP EPS of -$0.40 misses by $0.01
About
CEO | Mr. David A. Happel |
CFO | Mr. Thierry Chauche |
Address | 155 Bovet Road, San Mateo, CA, United States, 94402 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
